| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 1,152.68 | 1,034.09 | 879.61 | 859.50 |
| Accumulated Depreciation Total | -222.64 | -190.35 | -161.67 | -130.57 |
| Other Liabilities Total | 1.21 | 1.16 | 1.40 | 1.57 |
| Accrued Expenses | 9.69 | 0.82 | 0.22 | 0.26 |
| Long Term Debt | 139.36 | 122.09 | 121.13 | 149.50 |
| Common Stock Total | 8.87 | 8.47 | 8.47 | 8.47 |
| Other Equity Total | 15.87 | 28.58 | - | - |
| Other Current Assets Total | 0.19 | 0.16 | 0.09 | 0.08 |
| Prepaid Expenses | 7.05 | 5.25 | 4.93 | 3.31 |
| Total Assets | 1,152.68 | 1,034.09 | 879.61 | 859.50 |
| Current Portof LT Debt/ Capital Leases | 46.59 | 44.69 | 38.53 | 43.74 |
| Additional Paid- In Capital | 69.82 | 69.82 | 69.82 | 69.82 |
| Cash | 41.31 | 35.96 | 7.31 | 34.58 |
| Total Equity | 639.64 | 536.33 | 460.53 | 470.29 |
| Long Term Investments | 11.68 | 10.94 | 10.52 | 21.53 |
| Retained Earnings( Accumulated Deficit) | 545.09 | 429.47 | 382.24 | 392.01 |
| Total Common Shares Outstanding | 8.87 | 8.47 | 8.47 | 8.47 |
| Property/ Plant/ Equipment Total- Gross | 788.16 | 655.22 | 605.41 | 578.19 |
| Tangible Book Valueper Share Common Eq | 71.91 | 63.04 | 54.23 | 55.39 |
| Total Liabilities | 513.04 | 497.76 | 419.08 | 389.21 |
| Total Debt | 310.76 | 280.77 | 254.07 | 263.27 |
| Short Term Investments | 0.09 | 0.08 | 0.07 | 12.00 |
| Cashand Short Term Investments | 41.40 | 36.04 | 7.38 | 46.58 |
| Total Receivables Net | 219.15 | 250.17 | 171.49 | 71.65 |
| Notes Payable/ Short Term Debt | 124.80 | 114.00 | 93.79 | 67.91 |
| Deferred Income Tax | 48.10 | 42.80 | 41.02 | 39.55 |
| Accounts Receivable- Trade Net | 203.81 | 236.61 | 148.72 | 48.53 |
| Property/ Plant/ Equipment Total- Net | 565.52 | 464.87 | 443.74 | 447.63 |
| Minority Interest | 0.00 | - | - | - |
| Total Current Liabilities | 324.37 | 331.72 | 254.91 | 196.48 |
| Total Inventory | 286.68 | 242.27 | 226.75 | 255.44 |
| Accounts Payable | 113.92 | 151.32 | 113.15 | 72.86 |
| Other Currentliabilities Total | 29.37 | 20.90 | 9.22 | 11.71 |
| Total Long Term Debt | 139.36 | 122.09 | 121.75 | 151.62 |
| Intangibles Net | 2.13 | 2.66 | 1.47 | 1.37 |
| Other Long Term Assets Total | 9.89 | 7.86 | 7.62 | 7.63 |
| Note Receivable- Long Term | 8.99 | 13.87 | 5.61 | 4.30 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 554.47 | 533.89 | 410.65 | 377.05 |
| Capital Lease Obligations | 0.00 | 0.00 | 0.61 | 2.11 |
SMS Pharmaceuticals Dividend SMS Pharmaceuticals Bonus SMS Pharmaceuticals News SMS Pharmaceuticals AGM SMS Pharmaceuticals Rights SMS Pharmaceuticals Splits SMS Pharmaceuticals Board Meetings SMS Pharmaceuticals Key Metrics SMS Pharmaceuticals Shareholdings SMS Pharmaceuticals Profit Loss SMS Pharmaceuticals Cashflow SMS Pharmaceuticals Q1 Results SMS Pharmaceuticals Q2 Results SMS Pharmaceuticals Q3 Results SMS Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks